年齢によるレプチンの減少は,腫瘍のマイクロ環境におけるCD8+ T細胞の老化に寄与する
Feixiang Wang1, Rujuan Bao2, Shuiyu Xu3
1Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200062, China; Shanghai Institute of Immunology, Department of Immunology and Microbiology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Cell reports. Medicine
|August 26, 2025
まとめ
老化により 腫瘍のT細胞の老化を防ぐホルモンである レプチンが減少します レプチンのレベルが低下すると,CD8+ T細胞の老化が促進され,高齢者の抗がん免疫反応が弱まります.
科学分野:
- 免疫学
- ゲロントロジー
- 代謝に関する研究
背景:
- 高齢者におけるT細胞機能障害は癌の発生率を高めます
- 腫瘍の微小環境内のT細胞の老化のメカニズムは完全に理解されていません.
研究 の 目的:
- 腫瘍内の年齢に関連するT細胞衰老におけるアディポサイト由来レプチンの役割を調査する.
- 癌における代謝変化とT細胞の老化との関係を調べる
主な方法:
- ヒトとマウスの癌組織の単細胞プロファイリング
- T細胞の老化マーカーとレプチン濃度の分析
- 血レプチンと腫瘍内T細胞の老化との相関分析
主要な成果:
- 腫瘍内老化性CD8+T細胞は年齢とともに増加し,抗腫瘍免疫を低下させます.
- 脂肪細胞由来レプチンの減少は,CD8+ T細胞の老化の主要な要因である.
- レプチンシグナリングはp38依存のT細胞衰老を抑制する.
- 血レプチンの低下は,がん患者のT細胞老化率の上昇と相関する.
結論:
- 年齢に関連したレプチンの減少は,腫瘍の微小環境におけるT細胞の老化に寄与する.
- レプチンなどの代謝因子は T細胞の老化に 重要な役割を果たします
- レプチンのレベルを調節することは,高齢のがん患者のための治療戦略である可能性があります.
関連する概念動画
02:15Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:19Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62